Integrative analysis of disulfidptosis and immune microenvironment in hepatocellular carcinoma: a putative model and immunotherapeutic strategies

Integrative analysis of disulfidptosis and immune microenvironment in hepatocellular carcinoma: a putative model and immunotherapeutic strategies

BackgroundHepatocellular carcinoma (HCC) is a malignant tumor with a high rate of recurrence and m metastasis that does not respond well to current therapies and has a very poor prognosis. Disulfidptosis is a novel mode of cell death that has been analyzed as a novel therapeutic target for HCC cells...

Full description

Bibliographic Details
Main Authors:	Ti Yang, Junhao Liu, Fang Liu, Jiashun Lei, Siliang Chen, Zengxin Ma, Peifeng Ke, Qiaolan Yang, Jianfan Wen, Yifeng He, Juan Duan, Xiancheng Zeng
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-01-01
Series:	Frontiers in Immunology
Subjects:	HCC disulfidptosis putative model immune microenvironment NDRG1
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1294677/full

Similar Items

Novel application of the ferroptosis-related genes risk model associated with disulfidptosis in hepatocellular carcinoma prognosis and immune infiltration
by: Jiayan Wei, et al.
Published: (2024-02-01)

Integrated multi-level omics profiling of disulfidptosis identifis SPAG4 as an innovative immunotherapeutic target in glioblastoma
by: Shenbo Chen, et al.
Published: (2024-10-01)

Prognosis and chemotherapy drug sensitivity in liver hepatocellular carcinoma through a disulfidptosis-related lncRNA signature
by: Chao Chen, et al.
Published: (2024-03-01)

Identification and validation of immunity- and disulfidptosis-related genes signature for predicting prognosis in ovarian cancer
by: Miaojia Jin, et al.
Published: (2024-06-01)

Based on disulfidptosis-related glycolytic genes to construct a signature for predicting prognosis and immune infiltration analysis of hepatocellular carcinoma
by: Zhijian Wang, et al.
Published: (2023-08-01)

Role of disulfidptosis in colorectal adenocarcinoma: implications for prognosis and immunity
by: Ruanruan Yang, et al.
Published: (2024-09-01)

The role of molecular subtypes and immune infiltration characteristics based on disulfidptosis-related genes in ovarian cancer
by: Ruanruan Yang, et al.
Published: (2024-10-01)

Identification of subtypes and biomarkers associated with disulfidptosis-related ferroptosis in ulcerative colitis
by: Yinghao Jiang, et al.
Published: (2025-02-01)

Identification of disulfidptosis-related subtypes in gastric cancer and GAMT is a key gene during disulfidptosis
by: Wenxue Wu, et al.
Published: (2025-01-01)

Leveraging a disulfidptosis/ferroptosis-based signature to predict the prognosis of lung adenocarcinoma
by: Xiaoqing Ma, et al.
Published: (2023-11-01)

A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma
by: Ti Yang, et al.
Published: (2023-06-01)

Identification of disulfidptosis related subtypes, characterization of tumor microenvironment infiltration, and development of DRG prognostic prediction model in RCC, in which MSH3 is a key gene during disulfidptosis
by: Kai Xu, et al.
Published: (2023-06-01)

Leveraging a disulfidptosis-related signature to predict the prognosis and immunotherapy effectiveness of cutaneous melanoma based on machine learning
by: Yi Zhao, et al.
Published: (2023-10-01)

Identification of disulfidptosis-related clusters and construction of a disulfidptosis-related gene prognostic signature in triple-negative breast cancer
by: Jie Wu, et al.
Published: (2024-06-01)

Development and validation of disulfidptosis-related genes signature for patients with glioma
by: Jia Wang, et al.
Published: (2024-12-01)

Identification of a disulfidptosis-related genes signature for diagnostic and immune infiltration characteristics in endometriosis
by: Xiangyu Chang, et al.
Published: (2024-10-01)

Advances in the study of disulfidptosis in digestive tract tumors
by: Yue Chen, et al.
Published: (2025-02-01)

Typing and modeling of hepatocellular carcinoma based on disulfidptosis-related amino acid metabolism genes for predicting prognosis and guiding individualized treatment
by: Xuenuo Chen, et al.
Published: (2023-08-01)

Bioinformatics Identification and Experimental Verification of Disulfidptosis-Related Genes in the Progression of Osteoarthritis
by: Siyang Cao, et al.
Published: (2024-08-01)

Establishment of disulfidptosis-related LncRNA signature as biomarkers in colon adenocarcinoma
by: Hongfei Yao, et al.
Published: (2024-05-01)

Exploring the Relevance of Disulfidptosis to the Pathophysiology of Ulcerative Colitis by Bioinformatics Analysis
by: Xiong Z, et al.
Published: (2024-05-01)

Diagnostic and prognostic value of disulfidptosis-related genes in sepsis
by: Wenlu Zou, et al.
Published: (2024-12-01)

Disulfidptosis-related genes serve as potential prognostic biomarkers and indicate tumor microenvironment characteristics and immunotherapy response in prostate cancer
by: Rongbin Zhou, et al.
Published: (2024-06-01)

TACE responser NDRG1 acts as a guardian against ferroptosis to drive tumorgenesis and metastasis in HCC
by: Bufu Tang, et al.
Published: (2023-05-01)

Disulfidptosis-related signature elucidates the prognostic, immunologic, and therapeutic characteristics in ovarian cancer
by: Yunyan Cong, et al.
Published: (2024-04-01)

Disulfidptosis: A New Target for Parkinson’s Disease and Cancer
by: Tingting Liu, et al.
Published: (2024-09-01)

Identification of disulfidptosis-related genes and subgroups in Alzheimer’s disease
by: Shijia Ma, et al.
Published: (2023-08-01)

Disulfidptosis signature predicts immune microenvironment and prognosis of gastric cancer
by: Zitao Liu, et al.
Published: (2024-08-01)

Molecular landmarks of tumor disulfidptosis across cancer types to promote disulfidptosis-target therapy
by: Deze Zhao, et al.
Published: (2023-12-01)

A machine learning model and identification of immune infiltration for chronic obstructive pulmonary disease based on disulfidptosis-related genes
by: Sijun Li, et al.
Published: (2025-01-01)

Disulfidptosis-related signatures for prognostic and immunotherapy reactivity evaluation in hepatocellular carcinoma
by: Jiajing Zhao, et al.
Published: (2023-12-01)

Investigating the role of disulfidptosis related genes in radiotherapy resistance of lung adenocarcinoma
by: Xiaoxia Pan, et al.
Published: (2024-10-01)

Unveiling disulfidptosis-related biomarkers and predicting drugs in Alzheimer’s disease
by: Lei Huang, et al.
Published: (2024-08-01)

Clinical Diagnostic and Prognostic Potential of NDRG1 and NDRG2 in Hepatocellular Carcinoma Patients
by: Shaohua Xu, et al.
Published: (2022-06-01)

Identification and validation of a disulfidptosis-related genes prognostic signature in lung adenocarcinoma
by: Yanpeng Zhang, et al.
Published: (2024-01-01)

Identification of prognostic risk score of disulfidptosis-related genes and molecular subtypes in glioma
by: Qian Jiang, et al.
Published: (2024-03-01)

Disulfidptosis-related signature predicts prognosis and characterizes the immune microenvironment in hepatocellular carcinoma
by: Jun Tang, et al.
Published: (2024-01-01)

Comprehensive evaluation of disulfidptosis in intestinal immunity and biologic therapy response in Ulcerative Colitis
by: Lichao Yang, et al.
Published: (2024-07-01)

Epigenetic regulation of diverse cell death modalities in cancer: a focus on pyroptosis, ferroptosis, cuproptosis, and disulfidptosis
by: Shimeng Zhou, et al.
Published: (2024-04-01)

Clarifying new molecular subtyping and precise treatment of melanoma based on disulfidptosis-related lncRNA signature
by: Yue Lei, et al.
Published: (2024-09-01)